Source link : https://www.newshealth.biz/health-news/car-t-cell-therapy-for-kidney-cancer-builds-on-efficacy-record/
LOUISVILLE, Ky. — A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in treatment-refractory patients, according to updated results from a prospective study. Overall, a fourth of patients with CD70 total positive score (TPS) ≥50 had objective responses to ALLO-316, increasing to 40% of patients with fludarabine/cyclophosphamide (FC) lymphodepletion. Additionally, […]
Author : News Health
Publish date : 2024-11-09 22:55:47
Copyright for syndicated content belongs to the linked Source.